The HER2 status of disseminated tumor cells in the bone marrow of early breast cancer patients is independent from primary tumor and predicts higher risk of relapse
A. D. Hartkopf*, M. Banys, F. Meier-Stiegen, M. Hahn, C. Röhm, J. Hoffmann, G. Helms, F. A. Taran, M. Wallwiener, C. Walter, H. Neubauer, D. Wallwiener, T. Fehm
Dive into the research topics of 'The HER2 status of disseminated tumor cells in the bone marrow of early breast cancer patients is independent from primary tumor and predicts higher risk of relapse'. Together they form a unique fingerprint.